Are you Dr. White?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Division Of Neoplastic Diseases
Milwaukee, WI 53226Phone+1 414-805-6800Fax+1 414-805-6805
Summary
- Dr. Gilbert White, MD is an oncologist in Milwaukee, Wisconsin. He is currently licensed to practice medicine in Wisconsin and North Carolina. He is a Professor at Medical College of Wisconsin.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1975 - 1976- University of North Carolina HospitalsResidency, Internal Medicine, 1973 - 1975
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1971 - 1973
University of North Carolina at Chapel Hill School of MedicineClass of 1971
Certifications & Licensure
NC State Medical License 2022 - 2025
WI State Medical License 2005 - 2021- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1986
Clinical Trials
- Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease Start of enrollment: 1993 Oct 01
- Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency Start of enrollment: 1992 Mar 01
Publications & Presentations
PubMed
- 240 citationsRap1b is required for normal platelet function and hemostasis in miceMagdalena Chrzanowska-Wodnicka, Susan S. Smyth, Simone M. Schoenwaelder, Thomas Fischer, Gilbert C. White
The Journal of Clinical Investigation. 2005-03-01 - 161 citationsEffects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes me...Thomas A. Hughes, John T. Gwynne, Boyd R. Switzer, Charles Herbst, Gilbert C. White
The American Journal of Medicine. 1984-07-01 - 205 citationsSH2- and SH3-mediated interactions between focal adhesion kinase and Src.Jeffrey W. Thomas, Byron Ellis, Renee J. Boerner, Wilson B. Knight, Gilbert C. White
The Journal of Biological Chemistry. 1998-01-02
Press Mentions
Wisconsin Researchers Awarded $5.3 Million for NIH Precision Medicine ResearchAugust 31st, 2017
Grant Support
- Research Training In Transfusion MedicineNational Heart, Lung, And Blood Institute2010–2011
- Blood Dyscrasias And Transfusion MedicineNational Heart, Lung, And Blood Institute2010
- Initiative In Stem Cell BiologyNational Center For Research Resources2010
- Role Of Carboxyterminal Hypervariable Region In Rap1b FunctionNational Heart, Lung, And Blood Institute2009–2010
- The Role Of RAP1 In Integrin Activation And Platelet SignalingNational Heart, Lung, And Blood Institute2006–2007
- Administrative CoreNational Heart, Lung, And Blood Institute2006
- Extension Study To Characterize Bddrfviii Manufactured By Refacto AFNational Center For Research Resources2005
- Role Of Rap1b In Integrin Activation And Platelet SignalingNational Heart, Lung, And Blood Institute2004–2005
- Core A-- Adminsitrative CoreNational Heart, Lung, And Blood Institute2004
- Transfusion Medicine/Hemostasis Clinical Research Netwo*National Heart, Lung, And Blood Institute2002–2003
- Structure And Function Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1993–2003
- Recombinant Factor VIII SQ In Previously Treated Hemophilia ANational Center For Research Resources1999–2002
- R97 022: Intron A + Ribavirin For Hepatitis C &Inherited Coagulation DiseaseNational Center For Research Resources1999–2002
- Antihemophilic Factor (Af Rahf) In Prev Treated Severe Hemophilia ANational Center For Research Resources1999–2002
- Structure And Function Of The Beta Cytoplasmic DomainsNational Heart, Lung, And Blood Institute1998–2002
- Structure/Function Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1997–2002
- Predictors Of Inhibitors In Hemophilia ANational Center For Research Resources2000
- Factor VIII Vector For Treatment Of Severe Hemophilia ANational Center For Research Resources2000
- Antiretriviral Therapy &Indinavir Sulfate In HIV-1 HemophiliaNational Center For Research Resources2000
- Platelet Specific Knockout Of Signaling ProteinsNational Heart, Lung, And Blood Institute1997–2000
- Comparing Recombinant Factor VIII VS Hemofil(R)-M In HemophiliaNational Center For Research Resources1997–1999
- Three Segment Phase I/II Study In Previously Treated Hemophilia BNational Center For Research Resources1996–1999
- Internatl Symposium On Gene Therapy For HemophiliaNational Heart, Lung, And Blood Institute1997
- Study Of R-Viii SQ In Hemophilia A Patients During SurgeryNational Center For Research Resources1997
- Recombinant Human Factor IX In Previously Treated Patients With Hemophilia BNational Center For Research Resources1997
- Recombinant Factor VIII In The Treatment Of Previously Treated Hemophilia A PTSNational Center For Research Resources1997
- Ligand Binding Domains Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1995–1997
- Recombinant Factor VIII In Treatment Of Previously Treated Hemophilia A PatientsNational Center For Research Resources1995–1997
- Genetics Institute Protocol C9417-21--Recombinant Human Factor IXNational Center For Research Resources1996
- Effect Of Bleeding Time And Calculation Of Von Willebrand FactorNational Center For Research Resources1995
- Molecular Biology Of Cytoadhesins--Oral Tissue ModelNational Institute Of Dental &Craniofacial Research1987–1990
